Study Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations
Completed · Phase 1
Conditions studied: Arthritis
In brief
We will evaluate the bioavailability of naproxen 500 mg administered as three dfferent formulations.
Key facts
- Study ID
- NCT00665743
- Run by
- POZEN
- People needed
- 30
- Starts
- 2008-03-01
- Expected to finish
- 2008-06-01
- Last updated by the study team
- 2008-06-10
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy male or non-pregnant female subjects between 18-55 years of age as well as other standard inclusion criteria for a study of this nature
You may not qualify if…
- Standard exclusion criteria for a study of this nature
Where it is running
- Study site — Austin, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.